Abstract 4136621: Efficacy of Empagliflozin in Heart Failure with Preserved Ejection Fraction is related to the presence of echocardiographic features of diastolic dysfunction in the EMPEROR-Preserved trial.
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4136621
Abstract: Introduction: Efficacy of SGLT2i empagliflozin in Heart Failure is seen across the LVEF spectrum and in multiple clinical subgroups, with diverse mechanisms of action. We hypothesized that objective echo evidence of diastolic dysfunction (DD) in… read more here.
Keywords: diastolic dysfunction; empagliflozin heart; efficacy; emperor preserved ... See more keywords